
Clinical Briefs
Semaglutide Improves Kidney Outcomes in Type 2 Diabetes
In FLOW, semaglutide reduced major kidney outcomes and cardiovascular death among adults with type 2 diabetes and albuminuric chronic kidney disease.
Rayan Salih · August 13, 2026 · 6 min
